Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

Summary

This report is the companion to Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion (July 2020). IT covers contract manufacturing agreements for COVID-19 vaccines and drugs worldwide, across a range of different services and manufacturing scales. It covers clinical and commercial contracts. As COVID-19 pharmaceuticals are being ordered in billions of doses by numerous governments, the number of contract service agreements secured serves as an indicator of a CMOs performance. This report is critical for establishing an understanding of the overall CMO industry as it responds to the challenges and opportunities of the pandemic.

Scope

- This 52-page report gives an important expert quantitative analysis of the contract manufacturing industrys response to the COVID-19 pandemic. Findings are based on the industrys most comprehensive databases of the CMO industry (GlobalDatas Databases of Contract Service Providers, Drugs, and Deals).
- This analysis is primarily driven by the Deals Database, which is continuously updated and reveals manufacturing relationships for Pharma products and the types of services offered. The 23 figures and 6 tables throughout the report illustrate major points and trends. This report is required reading for -
- CMO executives who must have deep understanding of the COVID-19 vaccine and drug landscape -- both pipeline and marketed -- to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

- Overview of contract manufacturing agreements worldwide for COVID-19 pharmaceuticals and the levels of outsourcing associated with different services and drug type
- Detailed view of CDMO performance by contract manufacturing agreement and an assessment of their manufacturing scale
- Manufacturing agreements are assessed by different molecule types, service type, dose form, facility geography, sponsor company types, and CDMO types.

Table of Contents
1 Executive Summary
2 Players
3 Trends
4 Industry Analysis
5 Value Chain: Contract Manufacturing Service Agreements
6 Appendix
7 Companies
8 About the Authors

List Of Tables

List of Tables
Table 1: Top Trends in COVID-19 Contract Manufacturing
Table 2: Promising Pipeline Therapies
Table 3: Promising Pipeline Vaccines
Table 4: Marketed Therapies and Vaccines
Table 5: Further Reading
Table 6: CDMOs with COVID-19 Contract Manufacturing Agreements

List Of Figures

List of Figures
Figure 1: Leaders and Disruptors: Top Players in Outsourcing COVID-19 Vaccine/Therapeutic Manufacturing
Figure 2: Pipeline Therapies in Development for COVID-19
Figure 3: Pipeline Vaccines in Development for COVID-19
Figure 4: Clinical Trials of COVID-19 Therapies and Vaccines
Figure 5: The Contract Manufacturing Value Chain
Figure 6: COVID-19 Vaccine and Therapy Contract Manufacturing Agreements
Figure 7: Contract Manufacturing Agreements for COVID-19 Vaccines and Therapies - Manufacturing Facility Geography
Figure 8: Contract Manufacturing Agreements for COVID-19 Vaccines and Therapies - Manufacturing Facility Country
Figure 9: Contract Manufacturing Agreements for COVID-19 Vaccines - Manufacturing Facility Geography
Figure 10: Contract Manufacturing Agreements for COVID-19 Therapies - Manufacturing Facility Geography
Figure 11: COVID-19 Contract Manufacturing Agreements by Molecule Type
Figure 12: Contract Manufacturing Agreements by Service Type
Figure 13: Contract Manufacturing Agreements by Dosage Form
Figure 14: Outsourcing by API/Dose/Packaging
Figure 15: Count of Services Per Contract
Figure 16: Contract Manufacturing Agreements - Scale of Services
Figure 17: Top CDMOs by COVID-19 Contract Service Agreements
Figure 18: CDMOs with COVID-19 Contract Manufacturing Agreements - by Market Cap
Figure 19: Market Cap Bands of CDMOs (Therapies vs. Vaccines)
Figure 20: Contract Manufacturing Agreements by Top Products/Sponsors
Figure 21: Vaccine Contract Volume, Gamaleya and AstraZeneca
Figure 22: Vaccine API Contract Manufacturing Facilities, Worldwide
Figure 23: Vaccine API Contract Manufacturing Facilities, US

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available